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translational differences for comparison. Daily merged CT 
image was created for each patient by substituting the MVCT 
to corresponding portion of planning CT based on the offsets 
obtained during treatment verification. TomoTherapy 
Planned Adaptive software was used to recalculate the daily 
dose distribution on the merged CT. MIM software was used 
to accumulate all recalculated daily doses by deformable 
fusion to give the total actual dose. The mean percentage 
difference (MPD) between the actual and planned doses of 
targets and OARs were then calculated for analysis. 
 
  
Results: The setup deviation in supine position was 
significantly smaller than in prone position, in which the 
lateral, longitudinal, vertical and roll direction were 0.27 vs 
1.53 mm, 0.37 vs 1.23 mm, 0.37 vs 1.34 mm and 0.11 vs 0.43 
° for RE (all p < 0.05), and 2.08 vs 6.32 mm, 2.30 vs 4.62 
mm, 3.14 vs 4.61 mm and 0.31 vs 1.13 ° for SE respectively 
(all p < 0.05 except vertical direction). All dose results are 
shown in Table 1. For prone position, the MPDs of both CTV 
and PTV were significantly smaller in D2% (p = 0.0413), but 
they were greater in D95% and D98% in which PTV D98% showed 
significant difference (p = 0.0215). The opposite signs in MPD 
of D2% and D95%/ D98% in prone position implied the loss of 
target homogeneity. For OAR doses, the MPD were smaller in 
supine than in prone position except Dmean of contralateral 
breast and liver and V15Gy of heart. The actual heart dose was 
in fact increased in prone position (+ve MPD) while decreased 
in supine position. No significant results were found in MPD of 
all OARs.  
Conclusions: Supine position was found to have better 
geometric accuracy. The MPDs for most of the targets and 
OARs in supine position are smaller than that in prone 
position, implying higher accuracy in delivering the planned 
dose. All these suggested supine setup gain more patient 
stability during actual treatment. 
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Purpose/Objective: Comparisons of proton and photon dose 
distributions in treatment plans have clearly demonstrated 
that protons offers superior normal tissue sparing, decreased 
integral dose and excellent dose coverage in craniospinal (CS) 
irradiation (Howell et al, RO, 2012). However, protons are 
especially sensitive to range uncertainties and setup errors 
and have, if not properly accounted for in the planning 
process, the potential of causing large disturbances in the 
planned dose distribution. The aim of this study has been to 
analyse the effect of range uncertainties and setup errors in 
CS proton treatment plans.  
Materials and Methods: Intensity Modulated Proton 
Treatment plans (IMPT) was created for 6 paediatric patients 
in the Eclipse treatment planning system (Varian Medical 
Systems, Palo Alto, CA, USA). The CTV included the whole 
brain and the spinal canal to the junction area between the 
second and third sacral vertebrae. The CTV-PTV margin 
applied was 4 mm, in addition the PTV was expanded to also 
include the entire corpus vertebrae, this to avoid a possibly 
future asymmetric growth of the skeleton (Eifel et al, 
IJROBP, 1995). The beam arrangements consisted of 2 lateral 
oblique fields to cover the brain and the upper cervical 
spine, and 2 posterior fields to enable coverage of the whole 
spinal canal. The prescribed dose was 36 Gy (RBE) in 20 
fractions and evaluated by standard criteria. Setup errors 
were introduced by shifting the isocenter in the treatment 
plans by ±1-5 mm in lateral, longitudinal and vertical 
directions. Range errors was modelled by changing the 
Relative Stopping Power in the CT calibration curve for ±1-5 
%, thus generating a decrease (undershoot) or increase 
(overshoot) in the estimated proton range. The treatment 
plans where then recalculated with the initial spot 
distribution and evaluated in terms of CTV dose coverage and 
the doses to the heart, thyroid and lungs. 
Results: The largest reduction in the CTV dose was caused by 
a 5 mm caudal isocenter shift and an undershoot of 5 %, 
resulting in a reduction in the V95 % from 100 % to 97.7 % and 
97.3%, respectively. This corresponds to a percentage change 
of - 2.3 % and - 2.7 %, respectively (Table I). The heart dose 
was most sensitive to the range uncertainties and setup 
errors in the left direction, increasing the V5Gy(RBE) from 4.2% 
to 6,7 % with 5 mm left isocenter shifts or a 5 % overshoot. 
Range uncertainty had the largest impact on the thyroid 
dose, the V5Gy(RBE) from 50.9% to 72.3 % following a 5% 
overshoot. Only the LR setup error affected the lung dose, 
demonstrated by the increase in V5Gy(RBE) in the right lung due 
to the isocenter shifts in the right direction (Figure 1). 




Conclusions: In the IMPT treatment plans calculated in this 
study, the CTV dose coverage was only slightly affected by 
setup errors and range errors. The OARs appeared to be more 
sensitive for the introduced uncertainties, with a potentially 
significant increase of dose to the OARs. 
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Purpose/Objective: To investigate the dosimetric feasibility 
of a two-steps dose escalation strategy in patients affected 
by Malignant Pleural Mesothelioma (MPM) by using Helical 
Tomotherapy (HT). 
Materials and Methods: Twelve patients with MPM, treated 
using HT, were selected. The prescribed median doses to the 
planning target volume (PTV) boost, outlined by the FDG-
PET/CT and to the PTV (pleural cavity) were 61.6 Gy (range 
60-66 Gy) and 54 Gy (range 50.4-54 Gy) in 28-30 fractions, 
respectively. PTVs and Organs At Risk (OAR) were contoured 
by physicians according to institutional protocols. Inverse 
planning optimization was performed using the following 
parameters: Field Width = 2.5 cm, pitch = 0.287, final 
Modulation Factor ranged between 1.8 and 2.3. For each 
patient two dose escalation plans were generated prescribing 
62.5 Gy and 70 Gy (2.5 and 2.8Gy/fraction respectively) to 
the PTV boost and 56 Gy (2.24 Gy/fraction) to the PTV 
pleural cavity in 25 fractions. For the three treatment 
planning strategies, for each patient, the average dose to 
controlateral lung, lungs sum, liver, heart, esophagus, 
kidneys and small bowel were evaluated. QUANTEC Dose 
Volume Histograms (DVH) constraints were used for planning 
evaluation. The statistically difference among plans was 
tested by Mann-Whitney non parametric test (MedCalc 
statistics Software). 
Results: For all plans, the 95% PTV Volumes received at least 
the 95% of the prescribed dose.  
For all the considered OARs, the dosimetric constraints 
investigated are reported in figure 1. 
 
 
Figure 1. Mean 2 Gy Equivalent Doses and standard deviation 
of OARs (α/β = 3 Gy for all organs except for heart, α/β = 2 
Gy). 
For all plan strategies the average dose to the controlateral 
lung was always below 8 Gy. There was no dosimetric 
statistically significant difference between approved and 2.5 
Gy/fr (p>0.05) while a significant dosimetric difference 
between approved and 2.8 Gy/fr average doses of OARs 
